The note says the company filed a draft letter of offer for a proposed rights issue of up to Rs 1,300 crore.
Read this note →Natco Pharma Limited
NSE NATCOPHARM BSE 524816 INE987B01026
0 filings · 0 analysed
804.35
+1.89%
over 1 month
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing.
What the desks said
Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief